Although MFAP4 did not confer a role in myocardial infarction (MI) (STEMI + non-STEMI) (p = 0.304), in STEMI patients, declined plasma MFAP4 levels were more common (OR = 0.216, 95% CI 0.070–0.665, p = 0.008, Table 3). This evidence concerns the gene MFAP4 and myocardial infarction.